11 months oral miraclegro, 9 months topical roundup, 10 months spectracide, 6 months Cow Dung mesotherapy + weekly Foot stepping session 10/12/2025
The conversation humorously discusses hair loss treatments, mentioning "oral miraclegro," "topical roundup," "spectracide," "Cow Dung mesotherapy," and "weekly Foot stepping sessions." The user jokingly considers switching to "weed and feed" as a treatment.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity M24 Minoxidil + Finasteride 4 Months Progress
A user shared their 4-month progress using minoxidil foam twice daily and 1 mg finasteride tablets, showing significant hair growth. The user reported no side effects from finasteride and used Propecia, the only available brand in their region.
community What product does David Dobrik use
David Dobrik uses Minoxidil and possibly Finasteride for hair loss but applies them incorrectly. Users suggest he consider surgery due to his financial capability.
community Experience with oral minoxidil/cautionary tale
Oral minoxidil can cause severe side effects, including cardiac issues like shortness of breath and fluid retention, leading some users to stop its use. Many prefer topical minoxidil due to fewer systemic side effects, and there is anticipation for new formulations to minimize risks.
community People in Canada where are you guys getting oral minoxidil from?
Oral minoxidil is difficult to find in Canadian pharmacies, with many users suggesting online options like Essential Clinic, Phoenix, and UpGuys. Some users mention alternatives like compounding pharmacies or specific locations like Costco and Rexall.
community Oral minoxidil users, for your interest
Taking oral minoxidil in the morning may lead to better hair growth results compared to taking it at night. Some users combine it with finasteride and topical treatments, and there are discussions about splitting doses or adjusting timing to maximize benefits.
Related Research
6 / 6 resultsresearch Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
This study explored the effectiveness of the oral JAK1/2 inhibitor ruxolitinib in treating patients with moderate-to-severe alopecia areata, building on prior success with JAK inhibitors in mice, but results are not reported in this abstract.
research Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
This review outlines various dermatologic adverse events associated with targeted therapies and immunotherapies, emphasizing the need for collaboration between dermatologists and oncologists to manage these effects effectively; it reports no new clinical findings.
research Treatment of female pattern hair loss with oral antiandrogens
This study found that 88% of women with female pattern hair loss who received oral antiandrogens saw no progression or improvement in their condition.
research Placebo-controlled oral pulse prednisolone therapy in alopecia areata
In this study, oral prednisolone pulse therapy led to significant hair regrowth in some patients with extensive alopecia areata, whereas no improvement was seen in the placebo group.
research Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review
This systematic review concluded that the support for using spironolactone at commonly prescribed doses is based on evidence of limited quality.
research Oral retinoids-present status
This article reviews the current status of oral retinoids in dermatology and reports no new clinical findings.